Scadden David bought AGIO
June 18, 2026 · Form 4 insider transaction
Scadden David bought 14,950 shares of Agios Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,950
Price
$0.00
Total value
N/A
InsiderScadden David
Role—
SecurityStock options (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJune 23, 2026
Shares owned after14,950
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These options were granted on June 18, 2026. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2027.